{"id":"https://openalex.org/W7223865722","doi":"https://doi.org/10.7759/cureus.118681","title":"Efficacy and Safety of Stunnox\u2122 (Botulinum Toxin Type A) for the Treatment of Glabellar Frown Lines and Forehead Lines: A Prospective Observational Study in an Indian Cohort","display_name":"Efficacy and Safety of Stunnox\u2122 (Botulinum Toxin Type A) for the Treatment of Glabellar Frown Lines and Forehead Lines: A Prospective Observational Study in an Indian Cohort","publication_year":2026,"publication_date":"2026-10-27","ids":{"openalex":"https://openalex.org/W7223865722","doi":"https://doi.org/10.7759/cureus.118681","pmid":"https://pubmed.ncbi.nlm.nih.gov/42953836","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13716149"},"language":"en","primary_location":{"id":"doi:10.7759/cureus.118681","doi":"https://doi.org/10.7759/cureus.118681","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.118681","pdf_url":"https://www.cureus.com/articles/530697-efficacy-and-safety-of-stunnox-botulinum-toxin-type-a-for-the-treatment-of-glabellar-frown-lines-and-forehead-lines-a-prospective-observational-study-in-an-indian-cohort.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.cureus.com/articles/530697-efficacy-and-safety-of-stunnox-botulinum-toxin-type-a-for-the-treatment-of-glabellar-frown-lines-and-forehead-lines-a-prospective-observational-study-in-an-indian-cohort.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159959433","display_name":"Sandeep Arora","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327930874","display_name":"Apollo Hospitals","ror":"https://ror.org/02ew45630","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I1327930874"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Sandeep Arora","raw_affiliation_strings":["Dermatology, Apollo Hospitals, New Delhi, IND","Dermatology, Mehektagul Dermaclinic, New Delhi, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology, Apollo Hospitals, New Delhi, IND","institution_ids":["https://openalex.org/I1327930874"]},{"raw_affiliation_string":"Dermatology, Mehektagul Dermaclinic, New Delhi, IND","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028418317","display_name":"Gulhima Arora","orcid":"https://orcid.org/0000-0002-8365-3124","observed_orcids":["https://orcid.org/0000-0002-8365-3124"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gulhima Arora","raw_affiliation_strings":["Dermatology, Mehektagul Dermaclinic, New Delhi, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology, Mehektagul Dermaclinic, New Delhi, IND","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5138567115","display_name":"Rajesh Suresh Lalchandani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rajesh S Lalchandani","raw_affiliation_strings":["Medical Affairs, Gufic BioSciences, Mumbai, IND"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Affairs, Gufic BioSciences, Mumbai, IND","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5159959433"],"corresponding_institution_ids":["https://openalex.org/I1327930874"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.85888672,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"10","first_page":"e118681","last_page":"e118681"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11322","display_name":"Facial Rejuvenation and Surgery Techniques","score":0.8935999870300293,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11322","display_name":"Facial Rejuvenation and Surgery Techniques","score":0.8935999870300293,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11274","display_name":"Botulinum Toxin and Related Neurological Disorders","score":0.08980000019073486,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12301","display_name":"Facial Nerve Paralysis Treatment and Research","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/botulinum-toxin-type-a","display_name":"botulinum toxin type A","score":0.9610000252723694},{"id":"https://openalex.org/keywords/glabellar-frown-lines","display_name":"glabellar frown lines","score":0.9869999885559082},{"id":"https://openalex.org/keywords/forehead-lines","display_name":"forehead lines","score":0.9800000190734863},{"id":"https://openalex.org/keywords/cosmetic-procedures","display_name":"cosmetic procedures","score":0.42800000309944153},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.8370000123977661},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.8820000290870667},{"id":"https://openalex.org/keywords/facial-wrinkles","display_name":"facial wrinkles","score":0.39399999380111694}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9785000085830688},{"id":"https://openalex.org/C2780446394","wikidata":"https://www.wikidata.org/wiki/Q41055","display_name":"Forehead","level":2,"score":0.8256000280380249},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.7523000240325928},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.5597000122070312},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5033000111579895},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.4943999946117401},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4341999888420105},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.41179999709129333},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3538999855518341},{"id":"https://openalex.org/C2992435398","wikidata":"https://www.wikidata.org/wiki/Q6934595","display_name":"Multicenter study","level":3,"score":0.3312000036239624},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3025999963283539},{"id":"https://openalex.org/C2777367657","wikidata":"https://www.wikidata.org/wiki/Q184651","display_name":"Toxin","level":2,"score":0.26179999113082886},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2578999996185303}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.7759/cureus.118681","doi":"https://doi.org/10.7759/cureus.118681","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.118681","pdf_url":"https://www.cureus.com/articles/530697-efficacy-and-safety-of-stunnox-botulinum-toxin-type-a-for-the-treatment-of-glabellar-frown-lines-and-forehead-lines-a-prospective-observational-study-in-an-indian-cohort.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13716149","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13716149/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13716149/pdf/cureus-0018-00000118681.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Text"},{"id":"pmid:42953836","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42953836","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.7759/cureus.118681","doi":"https://doi.org/10.7759/cureus.118681","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.118681","pdf_url":"https://www.cureus.com/articles/530697-efficacy-and-safety-of-stunnox-botulinum-toxin-type-a-for-the-treatment-of-glabellar-frown-lines-and-forehead-lines-a-prospective-observational-study-in-an-indian-cohort.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223865722.pdf","grobid_xml":"https://content.openalex.org/works/W7223865722.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W1982905783","https://openalex.org/W1994696770","https://openalex.org/W2030462945","https://openalex.org/W2030883959","https://openalex.org/W2045780368","https://openalex.org/W2097878172","https://openalex.org/W2292150401","https://openalex.org/W2355600994","https://openalex.org/W2792575047","https://openalex.org/W2811177119","https://openalex.org/W2954808234","https://openalex.org/W3092200708","https://openalex.org/W4205608669","https://openalex.org/W4251143705","https://openalex.org/W4383301923","https://openalex.org/W4385298932","https://openalex.org/W4386565936","https://openalex.org/W4389192993","https://openalex.org/W4413176015"],"related_works":["https://openalex.org/W7119111255","https://openalex.org/W2910156340","https://openalex.org/W2077231061","https://openalex.org/W2320074195","https://openalex.org/W2908844873","https://openalex.org/W2331920778","https://openalex.org/W4239109975","https://openalex.org/W2022173954","https://openalex.org/W2569735253","https://openalex.org/W7118944566"],"abstract_inverted_index":{"Background":[0],"Botulinum":[1],"toxin":[2,41],"is":[3],"the":[4,27,92,108,122,146,156],"most":[5],"widely":[6],"performed":[7],"nonsurgical":[8],"aesthetic":[9],"procedure":[10],"globally,":[11],"but":[12],"efficacy":[13,28,262],"data":[14],"in":[15,48,270],"Indian":[16,49,271],"skin":[17,54],"phototypes":[18],"remain":[19],"limited.":[20],"Objective":[21],"This":[22],"study":[23],"aims":[24],"to":[25,145,166,170,235],"evaluate":[26],"(primary":[29],"endpoint:":[30],"complete":[31],"resolution":[32,152],"at":[33,91,130,155],"week":[34,177,187,224,277],"1)":[35,160],"and":[36,55,62,100,118,132,140,180,228,263,268],"safety":[37],"of":[38,231],"Stunnox\u2122":[39,83,258],"(botulinum":[40],"type":[42],"A":[43],"(BoNT-A);":[44],"Gufic":[45,85],"Biosciences,":[46,86],"India)":[47,87],"adults":[50,81],"with":[51,273],"Fitzpatrick":[52,79],"III-V":[53,80],"grade":[56],"1-2":[57],"glabellar":[58,241],"frown":[59],"lines":[60,64],"(GFL)":[61,179,227],"forehead":[63],"(FL)":[65,230],"over":[66],"20":[67,103,188],"weeks.":[68],"Methods":[69],"In":[70],"this":[71],"prospective,":[72],"single-center,":[73],"single-arm,":[74],"open-label,":[75],"investigator-initiated":[76],"study,":[77],"77":[78],"received":[82],"(BoNT-A;":[84],"for":[88,161,218,266],"GFL":[89,205,267],"(individualized":[90],"injector's":[93],"discretion,":[94],"9-17":[95],"U;":[96,246],"mean":[97],"12.4":[98],"U)":[99,250],"FL":[101,191,269],"(fixed":[102],"U).":[104],"Fifty":[105],"patients":[106,213,232],"completed":[107],"full":[109],"20-week":[110],"follow-up":[111],"(mean":[112],"age:":[113],"32.7":[114],"\u00b1":[115],"5.7":[116],"years)":[117],"were":[119],"scored":[120],"on":[121],"Facial":[123],"Wrinkle":[124],"Scale":[125],"(FWS)":[126],"(0-3,":[127],"dynamic":[128],"expression)":[129],"baseline":[131,196,237],"post-treatment":[133],"weeks":[134,220],"1,":[135],"4,":[136],"8,":[137],"12,":[138],"16,":[139],"20.":[141,278],"Analysis":[142],"was":[143,153,251],"restricted":[144],"completers":[147],"(50/77;":[148],"64.9%).":[149],"Results":[150],"Complete":[151],"observed":[154],"first":[157],"assessment":[158],"(week":[159],"both":[162],"regions":[163],"(GFL:":[164],"1.64":[165],"0;":[167,171],"FL:":[168],"1.18":[169],"p":[172],"<":[173,198],"0.0001),":[174],"sustained":[175],"through":[176],"12":[178],"16":[181],"(FL).":[182],"Partial":[183],"recurrence":[184,275],"appeared":[185],"by":[186,276],"(GFL":[189],"1.02;":[190],"0.96),":[192],"still":[193],"significantly":[194],"below":[195],"(p":[197],"0.001);":[199],"one":[200],"patient":[201],"(2%)":[202],"had":[203,214,233],"early":[204,261],"recurrence.":[206],"No":[207],"serious":[208],"adverse":[209],"events":[210],"occurred;":[211],"five":[212],"transient":[215],"brow":[216],"heaviness":[217],"four":[219],"without":[221,253],"ptosis.":[222],"By":[223],"20,":[225],"38%":[226],"78%":[229],"returned":[234],"their":[236],"grade.":[238],"Exploratory":[239],"severity-based":[240],"dosing":[242],"(Grade":[243],"1:":[244],"10.7":[245],"Grade":[247],"2:":[248],"13.3":[249],"used":[252],"a":[254],"fixed-dose":[255],"comparator.":[256],"Conclusions":[257],"showed":[259],"promising":[260],"short-term":[264],"tolerability":[265],"adults,":[272],"partial":[274]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-28T00:00:00"}